During the past decade, Central Dermatology PC conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 26 clinical trials were completed, i.e. on average, 144.4% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 17 clinical trials were completed. i.e. 283.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Dermatology PC" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Galderma R&D" with 7 trials sponsored, "Amgen" with 4 trials sponsored, "Coherus Biosciences, Inc." with 2 trials sponsored and "Janssen Research & Development, LLC" with 2 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Dermatology PC" #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "GlaxoSmithKline" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator and "Nektar Therapeutics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Central Dermatology PC" are "Psoriasis" (15 trials), "Atopic Dermatitis" (8 trials), "Plaque Psoriasis" (6 trials), "Acne Vulgaris" (2 trials) and "Rosacea" (2 trials). Many other conditions were trialed in "Central Dermatology PC" in a lesser frequency.

Most popular intervention types in "Central Dermatology PC" are "Drug" (35 trials), "Other" (5 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Apremilast" (3 trials), "Lebrikizumab" (3 trials), "Mirikizumab" (3 trials) and "Baricitinib" (2 trials). Other intervention names were less common.

The vast majority of trials in "Central Dermatology PC" are 41 trials for "All" genders.

Currently, there are NaN active trials in "Central Dermatology PC". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in Central Dermatology PC, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Central Dermatology PC, 1 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 0 trials that are defined as “Not Applicable".